Alopecia Areata (AA) is a common, non-scarring autoimmune alopecia affecting both children and adults. AA is the third most common dermatosis in children and has a significant emotional impact on patients, particularly children.
Melasma is a common acquired disorder of hyperpigmentation which has a strong predilection for females and is more common in individuals with Fitzpatrick skin phototypes III-VI.
Chronic urticaria (CU) occurs when pruritic wheals and/or angioedema manifests on most days of the week and persists for at least 6 weeks.
Non-invasive cosmetic procedures have increased 217.3% between 2012 and 2017, allowing for less risk and downtime than traditional aesthetic surgery.
The ongoing COVID-19 pandemic has changed our hand hygiene awareness and practices. Frequent handwashing or use of hand disinfectant have become far more common in our daily life and, though necessary to curb the spread of the virus, add further stress on our skin and skin barrier function.
Skin cancer is a leading cause of mortality and morbidity in the post-renal transplant patient. Squamous cell carcinoma (SCC) is the most common post-transplant malignancy (up to 250x more common than in the general population).
Targeting the p19 subunit of interleukin (IL)-23 has been a major development in the management of plaque psoriasis because of the durable efficacy and safety of this mechanism of action.
Tildrakizumab is a fully human monoclonal antibody that selectively targets the p19 subunit of interleukin-23 (IL-23).
Tildrakizumab is a high-affinity, humanized, IgG1 k antibody targeting interleukin 23 p19 to treat patients with chronic plaque psoriasis.
